Capricor Therapeutics Company
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.
Investors
Technology:
COVID, Stem cell therapy
Industry:
Cell Therapy, Public
Headquarters:
Los Angeles, California, United States
Founded Date:
2005-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
8
Total Funding:
66500504
Estimated Revenue:
Less than $1M
Last Funding Date:
2019-12-21
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership